Share：
Share this content in WeChat
X
[Chinese][PDF]98775
• Clinical Article •
Predictive value of susceptibility vessel sign for long-term neurologic outcomes in elder patients with malignant middle cerebral artery infarct
ZHAO Jingwei  WU Lei  ZHANG Shaolan  TIAN Duxue  SUI Xin  SHI Guangzhi  ZHOU Jianxin 

Cite this article as: Zhao JW, Wu Lei, Zhang SL, et al. Predictive value of susceptibility vessel sign for long-term neurologic outcomes in elder patients with malignant middle cerebral artery infarct[J]. Chin J Magn Reson Imaging, 2021, 12(5): 1-5. DOI:10.12015/issn.1674-8034.2021.05.001.


[Abstract] Objective To investigate the predictive value of susceptibility vessel sign (SVS) on susceptibility weighted imaging (SWI) for long-term neurologic prognosis in elder patients with malignant middle cerebral artery infarct (mMCAI). Materials andMethods Thirty-one mMCAI patients aged more than 60 years who had underwent decompressive hemicraniotomy (DHC) were respectively screened. We dichotomized them based on 12-month modified Rankin Scale (mRS) to those with favorable (mRS 0—3) and unfavorable (mRS 4—6), and the 2 groups were compared on differences in baseline, clinical and neuroimaging data, including the findings of SWI tests.Results The univariate and multivariate logistics analysis for these 2 groups of patients identified an independent association of the positive SVS with the long-term neurologic outcomes in elder mMCAI patients (adjusted OR=18.655, 95% CI 1.129 to 308.173; P=0.041), and this sign also showed a good agreement rate with the recanalization of the cerebral arteries which were responsible for the stroke manifested on MRA (Kappa=0.842, P=0.020). However, SVS only presented a good specificity (0.905, 95% CI 0.699—0.988) for the neurologic outcomes in elder mMCAI patients without a favorable sensitivity (0.700, 95% CI 0.348—0.933).Conclusions SVS can independently predict the long-term neurologic prognosis of elder patients with mMCAI, and particularly its negative results can accurately predict the poor outcomes of these patients.
[Keywords] susceptibility weighted imaging；susceptibility vessel sign；malignant middle cerebral artery infarct；elder ages；outcomes

ZHAO Jingwei1   WU Lei1   ZHANG Shaolan1   TIAN Duxue2   SUI Xin2*   SHI Guangzhi1*   ZHOU Jianxin1  

1 Department of Critical Care, Beijing Tiantan Hospital, Capital Medical University, Beijing 100070, China

2 Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China

Sui X, E-mail: lena_sui@163.com Shi GZ, E-mail: shiguangzhi@bjtth.org

Conflicts of interest   None.

ACKNOWLEDGMENTS This article is supported by Sailing Project for Key Medical Specialties of Beijing Hospitals Authority (No. ZYLX202109) and the Capital Characteristic Study of Clinical Application (No. Z181100001718068).
Received  2020-12-10
Accepted  2021-03-25
DOI: 10.12015/issn.1674-8034.2021.05.001
Cite this article as: Zhao JW, Wu Lei, Zhang SL, et al. Predictive value of susceptibility vessel sign for long-term neurologic outcomes in elder patients with malignant middle cerebral artery infarct[J]. Chin J Magn Reson Imaging, 2021, 12(5): 1-5. DOI:10.12015/issn.1674-8034.2021.05.001.

1
Zhang Y, Wang D, Wang Y, et al. Prevalence, incidence, and mortality of stroke in china: results from a nationwide population-based survey of 4806-87 Adults[J]. Circulation, 2017, 135(8): 759-771. DOI: 10.1161/CIRCU-LATIONAHA.116.025250.
2
Berrouschot J, Sterker M, Bettin S, et al. Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care[J]. Intensive Care Med, 1998, 24(6): 620-623. DOI: 10.1007/s001340050625.
3
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials[J]. Lancet Neurol, 2007, 6(3): 215-222. DOI: 10.1016/S1474-4422(07)70036-4.
4
Jüttler E, Unterberg A, Woitzik J, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke[J]. N Engl J Med, 2014, 370(12): 1091-1100. DOI: 10.1056/NEJMoa1311367.
5
Gul W, Fuller HR, Wright H, et al. A systematic review and meta-analysis of the effectiveness of surgical decompression in treating patients with malignant middle cerebral artery infarction[J]. World Neurosurg, 2018, 120: e902-e920. DOI: 10.1016/j.wneu.2018.08.189.
6
Chao SP, Chen CY, Tsai FY, et al. Predicting mortality in patients with "malignant" middle cerebral artery infarction using susceptibility-weighted magnetic resonance imaging: preliminary findings[J]. Medicine (Baltimore), 2016, 95(8): e2781. DOI: 10.1097/MD.0000000000002781.
7
Goto Y, Kumura E, Watabe T, et al. Prediction of malignant middle cerebral artery infarction in elderly patients[J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1389-1395. DOI: 10.1016/j.jstrokecerebrovasdis.2015.12.034.
8
Kang DW, Jeong HG, Kim DY, et al. Prediction of stroke subtype and rec-analization using susceptibility vessel sign on susceptibility-weighted magnetic resonance imaging[J]. Stroke, 2017, 48(6): 1554-1559. DOI: 10.1161/STROKEAHA.116.016217.
9
Darcourt J, Withayasuk P, Vukasinovic I, et al. Predictive value of susceptibility vessel sign for arterial recanalization and clinical improvement in ischemic stroke[J]. Stroke, 2019, 50(2): 512-515. DOI: 10.1161/STROKEAHA.118.022912.
10
Chalela JA, Haymore JB, Ezzeddine MA, et al. The hypointense MCA sign[J]. Neurology, 2002, 58(10): 1470. DOI: 10.1212/wnl.58.10.1470.
11
Sakamoto Y, Kimura K, Sakai K. M1 susceptibility vessel sign and hyperdense middle cerebral artery sign in hyperacute stroke patients[J]. Eur Neurol, 2012, 68(2): 93-97. DOI: 10.1159/000338308.
12
Pedro KM, Roberto KT, Chua AE. Safety and outcome of decompressive hemicraniectomy after recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke: a systematic review[J]. World Neurosurg, 2020, 144: 50-58. DOI: 10.1016/j.wneu.2020.08.088.
13
Göttsche J, Flottmann F, Jank L, et al. Decompressive craniectomy in malignant MCA infarction in times of mechanical thrombectomy[J]. Acta Neurochir (Wien), 2020, 162(12): 3147-3152. DOI: 10.1007/s00701-019-04180-0.
14
Peng G, Huang C, Chen W, et al. Risk factors for decompressive craniectomy after endovascular treatment in acute ischemic stroke[J]. Neurosurg Rev, 2020, 43(5): 1357-1364. DOI: 10.1007/s10143-019-01167-4.
15
Rumalla K, Ottenhausen M, Kan P, et al. Recent nationwide impact of mechanical thrombectomy on decompressive hemicraniectomy for acute ischemic stroke[J]. Stroke, 2019, 50(8): 2133-2139. DOI: 10.1161/STROKEAHA.119.025063.
16
Kamran S, Akhtar N, Salam A, et al. CT pattern of infarct location and not infarct volume determines outcome after decompressive hemicraniectomy for malignant middle cerebral artery stroke[J]. Sci Rep, 2019, 9(1): 17090. DOI: 10.1038/s41598-019-53556-w.
17
Wartenberg KE, Henkner J, Brandt S, et al. Effect of recanalization on cerebral edema, long-term outcome, and quality of life in patients with large hemispheric infarctions[J]. J Stroke Cerebrovasc Dis, 2020, 29(12): 105358. DOI: 10.1016/j.jstrokecerebrovasdis.
18
Kamran S, Salam A, Akhtar N, et al. Predictors of decompressive hemicraniectomy in malignant middle cerebral artery stroke[J]. Neurosurg Rev, 2019, 42(1): 175-181. DOI: 10.1007/s10143-018-0974-9.
19
Tracol C, Vannier S, Hurel C, et al. Predictors of malignant middle cerebral artery infarction after mechanical thrombectomy[J]. Rev Neurol (Paris), 2020, 176(7-8): 619-625. DOI: 10.1016/j.neurol.2020.01.352.
20
Goedemans T, Verbaan D, Coert BA, et al. Outcome after decompressive craniectomy for middle cerebral artery infarction: timing of the intervention[J]. Neurosurgery, 2020, 86(3): E318-E325. DOI: 10.1093/neuros/nyz522.
21
García-Feijoo P, Isla A, Díez-Tejedor E, et al. Decompressive craniectomy in malignant middle cerebral artery infarction: family perception, outcome and prognostic factors[J]. Neurocirugia (Astur), 2020, 31(1): 7-13. DOI: 10.1016/j.neucir.2019.07.001.
22
Huang P, Chen CH, Lin WC, et al. Clinical applications of susceptibility weighted imaging in patients with major stroke[J]. J Neurol, 2012, 259(7): 1426-1432. DOI: 10.1007/s00415-011-6369-2.

PREV
NEXT Differential diagnosis of pituitary macroadenomas and sellar meningiomas by MRI basic signs combined with ADC value
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn